← Evidence map

ArticleAngiogenesis2019

A new prognostic model for survival in second line for metastatic renal cell carcinoma: development and external validation.

Lisa Derosa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2019
2020
2021
2022
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 30739258